AbbVie Inc. 8-K

What Happened
AbbVie Inc. announced and furnished a press release reporting its first-quarter 2026 financial results for the quarter ended March 31, 2026. The company filed Form 8-K on April 29, 2026 (Item 2.02), and the press release is provided as Exhibit 99.1 to the report.

Key Details

• Filing date: April 29, 2026 (Form 8-K, Item 2.02: Results of Operations and Financial Condition).
• Period covered: Quarter ended March 31, 2026 (first quarter 2026).
• Exhibit: Press Release dated April 29, 2026 furnished as Exhibit 99.1 and incorporated by reference.
• The 8-K furnishes the press release announcing AbbVie’s quarterly financial results (earnings, revenue and related commentary are in the press release itself).

Why It Matters
This 8-K signals that AbbVie has released its latest quarterly earnings and revenue information, which are key inputs for investors assessing near-term performance and trends. Retail investors should review the furnished press release (Exhibit 99.1) for the specific earnings, revenue figures, and management commentary; follow-up filings (e.g., the company’s Form 10-Q) may provide additional detail and disclosures. Changes in reported results or guidance in the release can influence the stock and analyst expectations.